Table 2.
CSF results
| TC 1 | DC P 1 | Prot 1 | Sug 1 | ADA 1 | TB PCR | TC 2 | DC P 2 | Prot 2 | Sug 2 | IV ceftriaxone 2 g twice daily | Days of RX |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 560 | 2 | 70 | 33 | ND | ND | ND | ND | NA | NA | No | NA |
| 130 | 3 | 72 | 56 | ND | ND | ND | ND | NA | NA | No | NA |
| 220 | 2 | 95 | 23 | ND | ND | 1030 | 2 | 102 | 37 | Yes | *6 |
| 60 | 2 | 97 | 30 | 21.3 | Neg | 480 | 38 | 71 | 29 | Yes | †7 |
| 360 | 85 | 78 | 60 | ND | ND | ND | ND | NA | NA | Yes | NA |
| 20 | 50 | 208 | 43 | ND | ND | ND | ND | NA | NA | No | NA |
| 680 | 8 | 353 | 76 | ND | ND | ND | ND | NA | NA | No | NA |
| 50 | 97 | 47 | 11 | ND | ND | 160 | 44 | 174 | 0 | No | *10 |
| 140 | 12 | 25 | 29 | 10 | ND | 250 | 70 | 132 | 23 | Yes | †4 |
| 180 | 5 | 52 | 52 | ND | ND | ND | ND | NA | NA | Yes | NA |
| 90 | 10 | 210 | 15 | 15.5 | Neg | 100 | 40 | 123 | 22 | No | *20 |
| 130 | 21 | 60 | 24 | 10.6 | Neg | 300 | 95 | 35 | 27 | No | *15 |
TC 1-Total count of first CSF study; DC P 1-percentage of polymorphs in first CSF study; Prot 1- protein of first CSF study; Sug 1-sugar of first CSF study; TC 2-total count of second CSF study; DC P 2-percentage of polymorphs in second CSF study; Prot 2-protein of second CSF study; Sug 2-sugar of second CSF study; Days of Rx-days of treatment prior to repeat CSF study
(*
indicates that CSF study followed DOTS
†
indicates that it followed IV ceftriaxone 2 g twice daily on)
NA-not applicable.